Business Description
Sera Prognostics is a US-based company focused on women's health, specializing in blood tests that help predict pregnancy-related risks. Its main product, the PreTRM test, is a non-invasive blood test taken between weeks 18 and 20 of pregnancy to assess risk in women carrying a single baby. The company is also working on additional blood-based tools to predict conditions such as preeclampsia, fetal growth restriction, and the timing of birth. Founded in 2008 and based in Salt Lake City, Utah, Sera Prognostics aims to give healthcare providers earlier and more accurate information to support better pregnancy outcomes.
